Navigation Links
Springer publishes anthology with the Nanoethics Group
Date:4/28/2008

Springer and The Nanoethics Group have released a collection of important papers addressing a range of near-term issues related to nanotechnologys ethical and social implications. The anthology Nanotechnology and Society: Current and Emerging Ethical Issues tackles such contentious issues as environmental impact, health dangers, medical benefits, intellectual property, professional code of ethics, privacy, international governance, and more.

The anthology features sixteen papers focused on the most urgent issues arising from nanotechnology today and in the near future. Written by leading researchers, policy experts, and nanoethics scholars worldwide, the book is divided into five units: foundational issues; risk and regulation; industry and policy; the human condition; and selected global issues.

While there are also more distant and speculative issues in nanoethicsand weve touched upon some of them in our previous workit is important to also have a single volume focused on the more immediate problems facing nanotechnology, especially as policymakers and industry are interested in these issues first and foremost, said Patrick Lin, Ph.D., director for The Nanoethics Group.

The volume is co-edited by Fritz Allhoff (Western Michigan Univ.) and Patrick Lin (Cal Poly, SLO; Dartmouth College) and presents papers by notable names in nanotechnology and nanoethics, including (in order of appearance): Jean-Pierre Dupuy (Stanford), Paul Thompson (Michigan State Univ.), Arthur Zucker (Ohio Univ.), David Berube (North Carolina State Univ.), Thomas Powers (Univ. of Delaware), Ashley Shew (Virginia Tech), Jeroen van den Hoven (Delft Univ. of Tech., Netherlands), Drew Harris (Graves Dougherty Hearon & Moody), Raj Bawa (Bawa Biotechnology Consulting LLP), Summer Johnson (Albany Medical College), Jason Robert (Arizona State Univ.), and Joachim Schummer (Tech. Univ. of Darmstadt, Germany). Organizations such as Canadas Commission de l'thique de la Science et de la Technologie, the European Group on Ethics in Science and New Technologies, the Meridian Institute, and the Woodrow Wilson International Center for Scholars also contributed papers.


'/>"/>

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer
Source:Eurekalert

Related biology technology :

1. The Lancet Publishes Results From Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
2. Dendreon Publishes Manuscript on CD54 as a Surrogate Marker of Antigen Presenting Cell Activation
3. The Lancet Publishes Vasogens ACCLAIM Results
4. Consortium publishes Phase II map of human genetic variation
5. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
6. Circulation Publishes MERLIN TIMI-36 Data Showing Safety and Anti-Arrhythmic Effects of Ranexa(R)
7. Simcere Pharmaceutical Group to Participate in Credit Suisse 3rd Annual Healthcare Trip
8. Simcere Pharmaceutical Group Reports Proposed Private Sale of Ordinary Shares by Existing Shareholder
9. Campbell Alliance Adds Doug Linton, Former Cardinal Health Executive, to Executive Advisory Group
10. Sloning and the Kornberg group at Stanford University starting evaluation project regarding the synthesis of a Statistically Randomized Gene Library
11. James W. Backstrom, M.D., Named Chief Medical Officer of Foundation Radiology Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... SHANGHAI , Jan. 19, 2017 /PRNewswire -- ... medical device open-access capability and technology platform, today ... a leading biology focused preclinical drug discovery contract ... Biosciences will become a wholly-owned subsidiary of WuXi, ... core competences and providing greater services. The acquisition ...
(Date:1/19/2017)... and GAITHERSBURG, Md. , Jan. ... and Altimmune, Inc., a privately-held immunotherapeutics company targeting ... definitive agreement for the merger of PharmAthene and ... include Novartis Venture Fund, HealthCap, Truffle Capital and ... fully-integrated and diversified immunotherapeutics company with four clinical ...
(Date:1/19/2017)... ... January 18, 2017 , ... LabRoots , ... from around the world, was today awarded the "Best Science & Technology Social ... on merit and decided upon by a dedicated team of researchers and analysts. ...
(Date:1/19/2017)... Jan. 18, 2017  Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ... immune therapies for operable and inoperable solid tumor cancers, ... Technical Officer of NW Bio, will present at the ... at the Hyatt Regency Hotel in Miami, ... the session entitled "New Therapeutic Approaches – Expanding the ...
Breaking Biology Technology:
(Date:1/18/2017)... 18, 2017  In vitro diagnostic (IVD) companies were ... acquisitions (M&A), and Kalorama Information expects that trend to ... been shifting. Generally, uncertainty in reimbursement and healthcare reform ... has changed the acquisitions landscape. Instead of looking to ... buying partners outside of their home country and also ...
(Date:1/12/2017)... -- New research undertaken by Fit Small Business has ... were simply asked which office technology had they not used ... issue.  Insights on what will be key features ... and industry leaders including Penelope Trunk , Martin ... Some of these findings included; ...
(Date:1/6/2017)... 2017  Privately-held CalciMedica, Inc., announced that it ... of a novel calcium release-activated calcium (CRAC) channel ... Acute pancreatitis, sudden painful inflammation of ... can be very serious.  In severe cases it can ... hospital stays, time in the ICU and substantial ...
Breaking Biology News(10 mins):